Laura ClarkThe phrase "sexually transmitted diarrhea" went viral in October 2026, and for once, the alarming headline is not much of an exaggeration. A Centers for Disease Control and Prevention (CDC) analysis published in the Morbidity and Mortality Weekly Report found that extensively drug-resistant (XDR) Shigella strains now make up 8.5% of tested samples in the United States — up from zero percent between 2011 and 2015. With nearly 14,000 U.S. cases recorded through September 26, 2026, according to CDC provisional data, doctors and public health officials are asking a pointed question: Are Americans getting the right care for this?
So, Is "Sexually Transmitted Diarrhea" Actually a Real STI?
The short answer is yes — partially. Shigella is a bacterium that causes shigellosis, a diarrheal illness that most people associate with contaminated food or water. But since at least the early 2000s, researchers have documented Shigella spreading through sexual contact, particularly anal-oral exposure. The CDC has noted the bacteria is "endemic" in some communities of gay, bisexual, and other men who have sex with men (GBMSM).
What makes Shigella distinctive — and genuinely alarming — is how little of it you need to get sick. Exposure to as few as 10 organisms can cause infection, according to the CDC. For comparison, Salmonella typically requires thousands. That extremely low infectious dose is why it spreads so efficiently through sexual contact, shared objects, or even brief skin-to-fecal contact.
Symptoms include profuse diarrhea (sometimes bloody), fever, and severe stomach cramps. Most cases resolve within five to seven days. The problem, in 2026, is that a growing subset of those cases will not respond to the antibiotics most doctors reach for first.
Why Drug Resistance Is the Story Behind the Headlines
Until recently, Shigella infections were typically treated with ciprofloxacin or azithromycin — common, affordable oral antibiotics. Extensively drug-resistant strains are resistant to both, plus multiple other antibiotic classes. The CDC's MMWR report found that approximately one in three patients with XDR Shigella ended up hospitalized — a striking rate for what most people think of as a stomach bug.
"No optimal therapy has been established" for XDR shigellosis, the CDC report stated. Physicians may try oral carbapenems, pivmecillinam, or fosfomycin, but none of these are FDA-approved for this indication in the United States. Clinicians are urged to order antimicrobial susceptibility testing whenever possible — meaning culturing the stool, identifying the strain, and running it against a panel of antibiotics before prescribing.
That lab-first approach is not standard practice at a walk-in clinic or urgent care. Most providers will prescribe empirically — giving you the drug most likely to work — which is still appropriate for the majority of cases. But for someone carrying an XDR strain, that first prescription may do nothing. And in the time it takes to realize the antibiotic is not working, the infection can worsen significantly.
When the Standard Antibiotic Fails: A Real Pattern Playing Out Across the U.S.
Consider Jordan, a 28-year-old high school teacher in Austin, Texas. Jordan develops watery diarrhea, chills, and stomach cramping three days after a sexual encounter. Figuring it is probably food poisoning, Jordan waits two days, then visits an urgent care clinic. The provider prescribes a standard five-day course of azithromycin — the same drug often used for chlamydia and other STIs.
By day seven, Jordan's symptoms have not improved — if anything, the cramping has intensified and there is now blood in the stool. Jordan returns. A second antibiotic is tried. Another week passes. Still no improvement.
This is the clinical signature of XDR Shigella. If Jordan had seen an infectious disease physician or a sexual health specialist at that first follow-up visit, the doctor would have ordered stool culture and susceptibility testing — a process that takes 48 to 72 hours but identifies exactly which antibiotics the strain responds to. The appropriate alternative may be IV ertapenem (a carbapenem antibiotic), requiring an outpatient infusion suite or a brief hospital stay.
Here is the financial if/then that matters: a specialist consultation costs approximately $150 to $300 out of pocket, or a $40 to $60 specialist copay with insurance. Hospitalization for severe shigellosis — which occurred in roughly 1 in 3 XDR cases per the CDC study — runs between $12,000 and $30,000 for a 3- to 5-day stay. If Jordan is enrolled in a high-deductible health plan with a $5,000 annual deductible, that entire deductible comes due before insurance covers a single dollar of the hospital bill. An early specialist referral is not just medically smarter — it is dramatically cheaper.
Warning Signs That Mean You Need a Doctor
Most Shigella infections resolve on their own. The body clears the bacteria; supportive care — hydration, rest — is sufficient. But several warning signs should prompt an immediate medical visit rather than continued home management:
Diarrhea that is still worsening after 48 hours, especially if there is blood or mucus in the stool. Blood in diarrhea is not "normal" for any stomach illness and should always be evaluated.
Fever above 101.5°F (38.6°C) that does not improve after the first two days. Persistent fever suggests the infection is active and spreading.
Signs of dehydration: extreme thirst, dizziness when standing, no urination for more than eight hours, or confusion. Dehydration from severe diarrhea can escalate quickly, particularly in adults over 65 or children under five.
No improvement after completing a prescribed antibiotic. This is the critical red flag for drug resistance. Finishing a course of antibiotics with no relief is not a reason to try a second course of the same drug class — it is a reason to request stool culture and a specialist referral.
For people in higher-risk groups — including GBMSM, immunocompromised individuals, people experiencing homelessness, or those who have recently taken multiple antibiotic courses — the threshold for seeking care should be lower. The CDC data shows these groups carry XDR strains at elevated rates, and they have less physiological reserve for a prolonged illness.
Foodborne gastrointestinal outbreaks can follow a similar pattern of delayed diagnosis, as seen in the recent Cyclospora cases in Michigan and Indiana — where the lag between exposure and proper treatment led to more severe outcomes for some patients.
What to Do If You Think You Have Shigella
If symptoms are mild — no blood, no high fever, no underlying health conditions — you can monitor at home for 24 to 48 hours. Stay well-hydrated with water or an oral rehydration solution. Avoid anti-diarrheal medications like loperamide (Imodium) without physician guidance: slowing gut motility in a bacterial infection can trap organisms and worsen the illness.
If you are sexually active and have had recent anal-oral contact, mention this explicitly to your provider. Many primary care physicians do not yet routinely screen for Shigella as an STI. Asking for a stool culture alongside an STI panel ensures the right testing happens.
People with confirmed shigellosis should avoid preparing food, swimming, or using a hot tub for at least seven days after symptoms resolve, per CDC guidance. This applies not just to your household but to anyone who shares your bathroom or kitchen.
Drug-resistant bacterial gastrointestinal infections — whether linked to contaminated food, like the 2026 E. coli recall that prompted a nationwide frozen blueberry recall, or transmitted sexually — share one clinical principle: when a standard antibiotic fails, the next step is specialist evaluation, not a repeat prescription of the same drug class.
If your first antibiotic does not work, ask your provider about a referral to an infectious disease or sexual health specialist who has familiarity with drug-resistance profiles and the alternative treatment options available in 2026.
The Bigger Picture: An Old Infection Becoming Harder to Treat
The Shigella story fits the wider pattern of antimicrobial resistance that the CDC and World Health Organization have called one of the defining public health threats of the century. Drug-resistant gonorrhea, MRSA, drug-resistant tuberculosis — each follows the same arc of a manageable infection becoming progressively harder to treat as bacteria adapt faster than new drugs are developed.
What distinguishes XDR Shigella is the sexual transmission vector, which creates chains of spread not always visible to public health surveillance. When someone is embarrassed to mention contracting a gut infection through sex, they may not disclose contacts, may self-treat at home, or may receive inappropriate care from a provider who does not suspect that route of transmission.
Getting the right diagnosis starts with an honest conversation with a clinician. Sexual health physicians and infectious disease specialists can evaluate both the infection and the resistance profile, providing a treatment plan based on actual susceptibility data — not a best guess.
For the CDC's current clinical guidance on shigellosis prevention, symptoms, and treatment options, visit cdc.gov/shigella.
Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or symptoms you may be experiencing.
